Heat Biologics Piotroski F Score

HTBX -  USA Stock  

USD 2.90  0.07  2.36%

This module uses fundamental data of Heat Biologics to approximate its Piotroski F score. Heat Biologics F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Heat Biologics. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Heat Biologics financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please check Heat Biologics Altman Z Score, Heat Biologics Correlation, Heat Biologics Valuation, as well as analyze Heat Biologics Alpha and Beta and Heat Biologics Hype Analysis.

Heat Biologics Piotroski F Score 

Heat Biologics Total Debt is fairly stable at the moment as compared to the past year. Heat Biologics reported Total Debt of 2.13 Million in 2021. Debt Current is likely to rise to about 456.6 K in 2022, whereas Issuance Repayment of Debt Securities is likely to drop (106.4 K) in 2022. Heat Biologics Asset Turnover is fairly stable at the moment as compared to the past year. Heat Biologics reported Asset Turnover of 0.0391 in 2021. Book Value per Share is likely to rise to 6.72 in 2022, whereas EBITDA Margin is likely to drop (10.78)  in 2022.
At this time, it appears that Heat Biologics' Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
Piotroski F Score - Frail
Current Return On Assets
Change in Return on Assets
Cash Flow Return on Assets
Current Quality of Earnings (accrual)
Asset Turnover Growth
Current Ratio Change
Long Term Debt Over Assets Change
Higher Leverage
Change In Outstending Shares
Change in Gross Margin
No Change

Heat Biologics Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Heat Biologics is to make sure Heat Biologics is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Heat Biologics' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Heat Biologics' financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares19.8 M18.4 M
Significantly Up
Slightly volatile
Weighted Average Shares Diluted19.8 M18.4 M
Significantly Up
Slightly volatile
Total Assets154.1 M142.8 M
Significantly Up
Slightly volatile
Total Liabilities9.4 M10 M
Notably Down
Slightly volatile
Current Assets141.2 M130.9 M
Significantly Up
Slightly volatile
Current Liabilities4.8 M4.2 M
Fairly Up
Slightly volatile
Total Debt2.8 M2.1 M
Significantly Up
Gross Margin0.890.9
Fairly Down
Slightly volatile
Asset Turnover0.04010.0391
Fairly Up

Heat Biologics F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Heat Biologics' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Heat Biologics in a much-optimized way.

About Heat Biologics Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value per Share

Heat Biologics Book Value per Share is fairly stable at the moment as compared to the past year. Heat Biologics reported Book Value per Share of 6.55 in 2021

Heat Biologics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Heat Biologics from analyzing Heat Biologics' financial statements. These drivers represent accounts that assess Heat Biologics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Heat Biologics' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets16 M31.75 M28.5 M87.47 M100.59 M108.53 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(12.52 M)(16.48 M)(19.7 M)(25.62 M)(23.06 M)(23.67 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(12.52 M)(16.48 M)(19.7 M)(25.62 M)(23.06 M)(23.67 M)
Earnings before Tax(12.65 M)(16.72 M)(19.97 M)(26.05 M)(23.44 M)(24.06 M)
Average Equity9.41 M22.51 M19.78 M78.13 M89.85 M96.94 M
Enterprise Value9.34 M1.73 M6.85 M99.4 M114.31 M123.33 M
Free Cash Flow(6.46 M)(22.31 M)(12.99 M)(22.36 M)(20.12 M)(21.71 M)
Invested Capital(2.17 M)8.2 M8.56 M109.88 M126.36 M136.34 M
Invested Capital Average1.35 M3.07 M9.05 M63.4 M72.9 M78.66 M
Market Capitalization13.7 M22.79 M16.22 M122.4 M140.76 M151.87 M
Tangible Asset Value18 M35.57 M24.5 M122.74 M141.15 M152.3 M
Working Capital1.41 M23.84 M6.77 M110.14 M126.66 M136.66 M

About Heat Biologics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heat Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heat Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heat Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through T-cell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Heat Biologics Investors Sentiment

The influence of Heat Biologics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Heat Biologics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Heat Biologics Implied Volatility

Heat Biologics' implied volatility exposes the market's sentiment of Heat Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Heat Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Heat Biologics stock will not fluctuate a lot when Heat Biologics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heat Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heat Biologics' short interest history, or implied volatility extrapolated from Heat Biologics options trading.

Current Sentiment - HTBX

Heat Biologics Investor Sentiment

Most of Macroaxis users are currently bullish on Heat Biologics. What is your judgment towards investing in Heat Biologics? Are you bullish or bearish?
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Heat Biologics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Heat Biologics Altman Z Score, Heat Biologics Correlation, Heat Biologics Valuation, as well as analyze Heat Biologics Alpha and Beta and Heat Biologics Hype Analysis. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Heat Biologics Stock analysis

When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Heat Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heat Biologics. If investors know Heat Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heat Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.